BIOMERICA INC Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
BIOMERICA INC (BMRA) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 3.21 million shares for the 6-month period ending 2024-11-30, per its 10-Q filed 2025-01-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2025-01-14
- BIOMERICA INC antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-08-31 was 3.31M shares, a 39.90% increase year-over-year.
- BIOMERICA INC antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-08-31 was 2.36M shares.
- BIOMERICA INC antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2021-11-30 was 2.06M shares, a 47.10% increase year-over-year.
- BIOMERICA INC antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2021-08-31 was 2.08M shares, a 8.07% increase year-over-year.
- BIOMERICA INC antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 2.32M shares, a 11.54% increase from fiscal 2021.
- BIOMERICA INC antidilutive securities excluded from computation of earnings per share, amount for fiscal 2021 was 2.08M shares, a 16.33% increase from fiscal 2020.
- BIOMERICA INC antidilutive securities excluded from computation of earnings per share, amount for fiscal 2020 was 1.79M shares, a 21.21% increase from fiscal 2019.
- BIOMERICA INC antidilutive securities excluded from computation of earnings per share, amount for fiscal 2019 was 1.48M shares, a 29.65% increase from fiscal 2018.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|
| 2024-11-30 | 3.21M shares 10-Q · filed 2025-01-14 | ||||
| 2024-08-31 | 3.31M shares 10-Q · filed 2024-10-15 | ||||
| 2023-11-30 | 2.28M shares 10-Q · filed 2025-01-14 | ||||
| 2023-08-31 | 2.36M shares 10-Q · filed 2024-10-15 | ||||
| 2022-05-31 | 2.32M shares 10-K · filed 2022-08-29 | ||||
| 2022-02-28 | 2.34M shares 10-Q · filed 2022-04-14 | ||||
| 2021-11-30 | 2.06M shares 10-Q · filed 2022-01-12 | ||||
| 2021-08-31 | 2.08M shares 10-Q · filed 2021-10-14 | ||||
| 2021-05-31 | 2.08M shares 10-K · filed 2022-08-29 | ||||
| 2021-02-28 | 1.28M shares 10-Q · filed 2021-04-14 | 1.36M shares 10-Q · filed 2022-04-14 | |||
| 2020-11-30 | 1.40M shares 10-Q · filed 2022-01-12 | 1.33M shares 10-Q · filed 2021-01-14 | 1.40M shares 10-Q · filed 2021-01-14 | ||
| 2020-08-31 | 1.93M shares 10-Q · filed 2021-10-14 | ||||
| 2020-05-31 | 1.79M shares 10-K/A · filed 2021-10-14 | ||||
| 2020-02-29 | 476.36K shares 10-Q · filed 2021-04-14 | 483.66K shares 10-Q · filed 2021-04-14 | |||
| 2019-11-30 | 521.78K shares 10-Q · filed 2021-01-14 | 498.04K shares 10-Q · filed 2021-01-14 | |||
| 2019-08-31 | 1.42M shares 10-Q · filed 2020-10-15 | ||||
| 2019-05-31 | 1.48M shares 10-K · filed 2020-08-31 | ||||
| 2019-02-28 | 393.87K shares 10-Q · filed 2020-04-14 | 592.08K shares 10-Q · filed 2020-04-14 | |||
| 2018-11-30 | 509.10K shares 10-Q · filed 2020-01-14 | 534.55K shares 10-Q · filed 2020-01-14 | |||
| 2018-08-31 | 1.11M shares 10-Q · filed 2019-10-15 | ||||
| 2018-05-31 | 1.14M shares 10-K · filed 2018-08-29 | ||||
| 2017-11-30 | 604.12K shares 10-Q · filed 2018-01-17 | 551.21K shares 10-Q · filed 2018-01-17 | |||
| 2017-08-31 | 945.00K shares 10-Q · filed 2018-10-15 | ||||
| 2017-05-31 | 897.00K shares 10-K · filed 2018-08-29 | ||||
| 2016-11-30 | 710.24K shares 10-Q · filed 2018-01-17 | 717.00K shares 10-Q · filed 2018-01-17 | |||
| 2016-08-31 | 1.25M shares 10-Q · filed 2017-10-16 | ||||
| 2016-05-31 | 1.20M shares 10-K · filed 2017-08-29 | ||||
| 2016-02-29 | 484.98K shares 10-Q · filed 2016-04-14 | 415.96K shares 10-Q · filed 2016-04-14 | |||
| 2015-11-30 | 321.67K shares 10-Q · filed 2017-01-17 | 401.91K shares 10-Q · filed 2017-01-17 | |||
| 2015-08-31 | 1.11M shares 10-Q · filed 2016-10-17 | ||||
| 2015-05-31 | 1.15M shares 10-K · filed 2016-08-29 | ||||
| 2015-02-28 | 364.32K shares 10-Q · filed 2016-04-14 | 403.52K shares 10-Q · filed 2016-04-14 | |||
| 2014-11-30 | 344.02K shares 10-Q · filed 2016-01-14 | 371.73K shares 10-Q · filed 2016-01-14 | |||
| 2014-08-31 | 852.25K shares 10-Q · filed 2015-10-15 | ||||
| 2014-05-31 | 860.50K shares 10-K · filed 2015-08-31 | ||||
| 2014-02-28 | 359.01K shares 10-Q · filed 2015-04-14 | ||||
| 2013-11-30 | 372.82K shares 10-Q · filed 2015-01-14 | 379.18K shares 10-Q · filed 2015-01-14 | |||
| 2013-08-31 | 864.50K shares 10-Q · filed 2014-10-15 | 0.00 shares 10-Q · filed 2013-10-15 | |||
| 2013-05-31 | 0.00 shares 10-K · filed 2014-08-29 | ||||
| 2013-02-28 | 910.63K shares 10-Q · filed 2014-04-14 | ||||
| 2012-08-31 | 85.00K shares 10-Q · filed 2013-10-15 | ||||
| 2012-05-31 | 195.00K shares 10-K · filed 2013-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |